share_log

Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"

Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"

Nexalin Technology已收到批准其美国专利申请18/342,590的通知,该专利名为 “治疗阿尔茨海默氏症和痴呆症的经颅交流电动态频率刺激(TACS)方法”
Benzinga ·  05/01 01:03

Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"

Nexalin Technology已收到批准其美国专利申请18/342,590的通知,该专利名为 “治疗阿尔茨海默氏症和痴呆症的经颅交流电动态频率刺激(TACS)方法”

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发